For example, a pan-cancer analysis of CLDN6 showed it is minimally expressed in most normal adult tissues but activated in several cancers (germ cell tumors, gynecologic cancers), correlating with worse outcomes (104). Here, CLDN6 is linked to female reproductive organ cancer.